Back

John L. Bell

John L. Bell

University of Tennessee Graduate School of Medicine, USA

Title: Using USA guidelines and standards of breast cancer care in an academic medical center: screening to survivorship

Biography

Dr. John L. Bell, received his medical degree from the University of Alabama/Birmingham, where he stayed to do his general surgical training, completed in 1986. A surgical oncology fellowship was completed in 1988 at the MD Anderson Cancer Center. Dr. Bell was recruited by the University of Tennessee to develop a Division of Surgical Oncology and an oncology program. He belongs to organizations such as the Southern Surgical Association, the American College of Surgeons, and the American Society of Breast Surgeons. He is the immediate past-president of the National Consortium of Breast Centers 2011-2013. He is certified by the American Board of Surgery, a Professor in the Department of Surgery, and Director of the UT Medical Center Cancer Institute.

Abstract

The cost of healthcare in the United States is higher than all other developed countries. Despite these expenditures, outcomes lag behind others especially the United Kingdom, when looking at variables such as quality, access, efficiency, equity and healthy lives. The National Comprehensive Cancer Network, The American Society of Clinical Oncology, The United States Preventive Services Task Force, The National Cancer Institute, along with other organizations are increasing their focus on value-based, evidence-based cancer care as the United States transitions to the era of the Affordable Care Act (ACA). The ACA in some ways mimics the successful program now in place for many years in the United Kingdom which ranks number 1 in three of the five categories noted above. The full discussion of this abstract will review the latest cancer facts and figures in the United States and contrast those to other developed countries such as the United Kingdom. Appropriate risk reduction and prevention strategies, cancer screening controversies, diagnostic testing, treatment options, surveillance and survivorship data will be tabulated, reviewed, and discussed with an economic focus.